Payment overview · 2025
General Payments
$1,102.22
8 reported records · 1 companies
Healthcare provider profile · identity verified
Andrew Knubel Perry, MD
Allopathic & Osteopathic Physicians|Internal Medicine · EDMONDS, WA · NPI 1114990975
Verified facts
What the public records show
CMS Open Payments records show Andrew Knubel Perry, MD received $1,102.22 in general payments during 2025 across 8 reported records.
INTUITIVE SURGICAL, INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| INTUITIVE SURGICAL, INC. | Unresolved — no canonical attribution shown | $1,102.22 | 100.0% | 8 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,102.22 | 8 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Da Vinci Surgical System Normalized: da vinci surgical system |
Device | INTUITIVE SURGICAL, INC. | $1,102.22 | 8 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 661 | 146 |
| Lisinopril | Lisinopril | 352 | 80 |
| Amlodipine Besylate | Amlodipine Besylate | 345 | 83 |
| Omeprazole | Omeprazole | 266 | 66 |
| Levothyroxine Sodium | Levothyroxine Sodium | 233 | 42 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 223 | 31 |
| Oxycodone Hcl | Oxycodone Hcl | 223 | 37 |
| Losartan Potassium | Losartan Potassium | 219 | 52 |
| Furosemide | Furosemide | 207 | 32 |
| Metformin Hcl Er | Metformin Hcl | 195 | 41 |
| Gabapentin | Gabapentin | 190 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 189 | 38 |
| Famotidine | Famotidine | 184 | 39 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 181 | 55 |
| Metoprolol Succinate | Metoprolol Succinate | 163 | 35 |
| Trazodone Hcl | Trazodone Hcl | 160 | 35 |
| Jardiance | Empagliflozin | 152 | 37 |
| Fluticasone Propionate | Fluticasone Propionate | 144 | 45 |
| Metformin Hcl | Metformin Hcl | 144 | 41 |
| Hydrochlorothiazide | Hydrochlorothiazide | 127 | 38 |
| Pregabalin | Pregabalin | 127 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 124 | 13 |
| Buspirone Hcl | Buspirone Hcl | 122 | 26 |
| Potassium Chloride | Potassium Chloride | 122 | 23 |
| Tramadol Hcl | Tramadol Hcl | 115 | 26 |
| Fluoxetine Hcl | Fluoxetine Hcl | 110 | 12 |
| Lorazepam | Lorazepam | 104 | 24 |
| Sertraline Hcl | Sertraline Hcl | 103 | 26 |
| Diclofenac Sodium | Diclofenac Sodium | 97 | 34 |
| Bupropion Xl | Bupropion Hcl | 96 | 16 |
| Clonazepam | Clonazepam | 95 | suppressed |
| Ozempic | Semaglutide | 92 | 17 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 89 | 27 |
| Baclofen | Baclofen | 81 | 15 |
| Meloxicam | Meloxicam | 79 | 25 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 78 | 24 |
| Eliquis | Apixaban | 76 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 75 | 16 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 74 | 18 |
| Ondansetron Odt | Ondansetron | 74 | 27 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 74 | 24 |
| Alprazolam | Alprazolam | 72 | 15 |
| Glipizide Er | Glipizide | 72 | 18 |
| Celecoxib | Celecoxib | 71 | 18 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 69 | 17 |
| Aripiprazole | Aripiprazole | 67 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 67 | 17 |
| Chlorthalidone | Chlorthalidone | 63 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 63 | 14 |
| Morphine Sulfate Er | Morphine Sulfate | 62 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 62 | 32 |
| Duloxetine Hcl | Duloxetine Hcl | 61 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 60 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 59 | 14 |
| Finasteride | Finasteride | 57 | 19 |
| Ketoconazole | Ketoconazole | 57 | 17 |
| Atenolol | Atenolol | 56 | 14 |
| Methocarbamol | Methocarbamol | 55 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 54 | suppressed |
| Lamotrigine | Lamotrigine | 52 | suppressed |
| Mirtazapine | Mirtazapine | 52 | 13 |
| Allopurinol | Allopurinol | 51 | 12 |
| Trulicity | Dulaglutide | 51 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 49 | suppressed |
| Topiramate | Topiramate | 49 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 48 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 47 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 47 | suppressed |
| Pantoprazole Sodium | Pantoprazole Sodium | 47 | 15 |
| Olanzapine | Olanzapine | 46 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 45 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 45 | 14 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 44 | 13 |
| Lidocaine | Lidocaine | 44 | 13 |
| Myrbetriq | Mirabegron | 44 | suppressed |
| Simvastatin | Simvastatin | 44 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 44 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 43 | 12 |
| Spironolactone | Spironolactone | 43 | 19 |
| Montelukast Sodium | Montelukast Sodium | 41 | suppressed |
| Nystatin | Nystatin | 41 | 19 |
| Nortriptyline Hcl | Nortriptyline Hcl | 40 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 39 | suppressed |
| Mounjaro | Tirzepatide | 39 | suppressed |
| Risperidone | Risperidone | 39 | suppressed |
| Diazepam | Diazepam | 38 | suppressed |
| Estradiol | Estradiol | 38 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 37 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 36 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 35 | suppressed |
| Xarelto | Rivaroxaban | 35 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 34 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 34 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 34 | suppressed |
| Ibuprofen | Ibuprofen | 33 | 13 |
| Prazosin Hcl | Prazosin Hcl | 33 | suppressed |
| Prednisone | Prednisone | 33 | 15 |
| Propranolol Hcl | Propranolol Hcl | 32 | suppressed |
| Loperamide | Loperamide Hcl | 31 | suppressed |
| Glipizide | Glipizide | 30 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 30 | suppressed |
| Testosterone | Testosterone | 30 | suppressed |
| Mupirocin | Mupirocin | 28 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 28 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 27 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 27 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 26 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 26 | suppressed |
| Acyclovir | Acyclovir | 25 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 15 |
| Terbinafine Hcl | Terbinafine Hcl | 25 | 14 |
| Westab Plus | Pnv,calcium 72/Iron/Folic Acid | 25 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 24 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 24 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 23 | suppressed |
| Carbamazepine | Carbamazepine | 22 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 22 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 22 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Torsemide | Torsemide | 22 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 21 | 11 |
| Divalproex Sodium | Divalproex Sodium | 21 | suppressed |
| Nyamyc | Nystatin | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 20 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 20 | suppressed |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 20 | suppressed |
| Carisoprodol | Carisoprodol | 19 | suppressed |
| Naproxen | Naproxen | 19 | suppressed |
| Sucralfate | Sucralfate | 19 | suppressed |
| Synthroid | Levothyroxine Sodium | 19 | suppressed |
| Vascepa | Icosapent Ethyl | 19 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Levetiracetam | Levetiracetam | 18 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 18 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 18 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 18 | suppressed |
| Carvedilol | Carvedilol | 17 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 17 | suppressed |
| Invokana | Canagliflozin | 17 | suppressed |
| Norgestimate-Ethinyl Estradiol | Norgestimate-Ethinyl Estradiol | 17 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 17 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 17 | suppressed |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 16 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 16 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 16 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 15 | suppressed |
| Sure Comfort Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 12 |
| Bumetanide | Bumetanide | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 14 | suppressed |
| Entacapone | Entacapone | 14 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 14 | suppressed |
| Linzess | Linaclotide | 14 | suppressed |
| Methadone Hcl | Methadone Hcl | 14 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 14 | suppressed |
| Creon | Lipase/Protease/Amylase | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Ezetimibe | Ezetimibe | 13 | suppressed |
| Memantine Hcl | Memantine Hcl | 13 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 13 | suppressed |
| Tradjenta | Linagliptin | 13 | suppressed |
| Zafirlukast | Zafirlukast | 13 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Lyrica | Pregabalin | 12 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 12 | suppressed |
| Singulair | Montelukast Sodium | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Temazepam | Temazepam | 12 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 11 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | suppressed |
| Glimepiride | Glimepiride | 11 | suppressed |
| Victoza 3-Pak | Liraglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $1,102.22 · 8 records | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error